Statin Contrast Induced Nephropathy Prevention

• Status: Completed
• Trial end date: 2012-10-01

Summary

This open-label study, prospective, randomized trial evaluating the acute (in-hospital) pleiotropic and clinical effects of a hydrophilic statin (rosuvastatin) in patients with acute coronary syndrome

• Phase: Phase 4

Details

• Lead Sponsor: Centro Cardiopatici Toscani
• Treatments: Rosuvastatin Calcium